Veradermics Inc.

Veradermics Inc.

Private
New Haven, ConnecticutHealthcare & Life Scienceshttp://www.veradermics.com

Last Round

Early Stage

VC

May 15, 2026

Est. Valuation

$596.3M

Total Funding Raised

$245.7M

Momentum Score

100 /100

Company Overview

Veradermics Inc. is a biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions such as pattern hair loss, common warts, and molluscum contagiosum.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

oral minoxidilhair loss pillpattern hair loss treatmentdermatology therapeuticsandrogenetic alopeciaextended-release technologyprescription dermatologyaesthetic medicinedissolvable microarray patchmicroneedle patchwart treatmentalopecia areataatopic dermatitisdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veradermics Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Veradermics Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMay 15, 2026
IPO AnnouncedFeb 3, 2026
Series COct 16, 2025
Series BDec 11, 2024
Series ASep 22, 2021

Key People

Founding team and executive leadership

Reid Waldman

Chief Executive Officer, Founder

Founding Team

Dominic Carrano

Chief Financial Officer

Executive Team

Veradermics Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2026

    Open roles increased to 7, 2.5x the trailing average.

  • May 15, 2026

    Raised $30M in an early stage VC round.

Veradermics Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Veradermics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Veradermics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Employee Range41
Year Founded2019
Last FundingMay 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.